9/20/24 16:20 | 9/12/24 | NRBO | Health | Drug | Pharmaceutical Preparations | Dong-A St Co., Ltd | M5 | T | | S.d | -2 | 3.75 | 0 | 0 | 0 | 5,348 | D | | | | | | | | | | | | | | |
7/10/24 11:11 | 6/23/24 | NRBO | Health | Drug | Pharmaceutical Preparations | Dong-A St Co., Ltd | M5 | T | | P.a | 10,000 | 3.93 | 0 | 2,545 | 91 | 5,348 | D | | | | | | | | | | | | | | |
6/25/24 16:16 | 6/23/24 | NRBO | Health | Drug | Pharmaceutical Preparations | Dong-A St Co., Ltd | M5 | T | | P | 7,964 | 3.13 | 0 | 2,545 | 91 | 5,348 | D | | | | | | | | | | | | | | |
2/12/18 16:40 | 2/8/18 | GEMP | Health | Drug | Pharmaceutical Preparations | Reno Seth | MI | O | Chief Co | P | 100 | 7.00 | 0 | 14 | 357 | 18 | D | | | | | | | | | | | | | | |
8/16/17 16:10 | 8/14/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Mathiesen Jeffrey S | MI | O | CFO | M.d | 12 | 3.59 | 0 | 3 | 29 | 14 | D | | | | | | | | | | | | | | |
8/15/17 16:22 | 8/10/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Mathiesen Jeffrey S | MI | O | CFO | M.ad | 11 | 3.59 | 0 | 3 | 38 | 11 | D | | | | | | | | | | | | | | |
8/11/17 16:07 | 8/10/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Mathiesen Jeffrey S | MI | O | CFO | M.d | 11 | 3.59 | 0 | 3 | 38 | 11 | D | | | | | | | | | | | | | | |
8/2/17 16:11 | 7/31/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Bisgaier Charles Phd | MI | DOT | Chief Sc | M.d | 6 | 1.34 | 0 | 4 | 0 | 1,350 | D | | | | | | | | | | | | | | |
3/14/17 18:07 | 3/10/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Sassine Andy | MI | D | | P.d | 200 | 9.47 | 0 | 21 | 18 | 136 | D | | | -26 | 2 | -12 | -7 | -3 | -3 | 1 | 11 | 24 | | | |
3/14/17 17:57 | 3/10/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | MI | D | | P.d | 100 | 9.47 | 0 | 11 | 21 | 60 | D | | | -26 | 2 | -12 | -7 | -3 | -3 | 1 | 11 | 24 | | | |
3/14/17 17:46 | 3/10/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Hawryluk P. Kent | MI | D | | P.d | 237 | 9.47 | 0 | 25 | 28 | 114 | I | | | -26 | 2 | -12 | -7 | -3 | -3 | 1 | 11 | 24 | | | |
3/14/17 17:33 | 3/10/17 | GEMP | Health | Drug | Pharmaceutical Preparations | Gullans Steven R. Ph.D. | MI | D | | P.d | 500 | 9.47 | 0 | 53 | 7 | 859 | I | | | -26 | 2 | -12 | -7 | -3 | -3 | 1 | 11 | 24 | | | |
8/12/16 13:27 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Hawryluk P. Kent | MI | D | | P.d | 250 | 10.00 | 0 | 25 | 39 | 89 | I | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 13:19 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | MI | D | | P.d | 100 | 10.00 | 0 | 10 | 25 | 49 | D | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 13:15 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Kousky Kenneth W | MI | D | | P.d | 10 | 10.00 | 0 | 1 | 0 | 224 | M | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 13:09 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Gullans Steven R. Ph.D. | MI | D | | P.d | 5,000 | 10.00 | 0 | 500 | 163 | 806 | I | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 13:06 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Reno Seth | MI | O | Chief Co | P | 40 | 10.00 | 0 | 4 | New | 4 | D | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 13:01 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Sooch Mina | MI | DO | P,CEO | P.d | 525 | 10.00 | 0 | 53 | 8 | 733 | M | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 12:54 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Lowenschuss David | MI | O | GC,Secre | P | 111 | 10.00 | 0 | 11 | 1 | 806 | D | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 12:49 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Mathiesen Jeffrey S | MI | O | CFO | P.d | 40 | 10.00 | 0 | 4 | 102 | 8 | D | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
8/12/16 12:47 | 8/10/16 | GEMP | Health | Drug | Pharmaceutical Preparations | Bisgaier Charles Phd | MI | DOT | Chair,Ch | P.d | 518 | 10.00 | 0 | 52 | 4 | 1,346 | M | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |